IDEX
IEX

$195.14

0.83%

Market Cap: $14.8B

About: Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2023.

Employees: 8,800

Industrials Pumps & Pumping Equipment

0

Funds holding %

of 6,686 funds

0

Analysts bullish %

of 6 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

24% more repeat investments, than reductions

Existing positions increased: 241 | Existing positions reduced: 194

20% more funds holding in top 10

Funds holding in top 10: 5 [Q1] → 6 (+1) [Q2]

11% more first-time investments, than exits

New positions opened: 72 | Existing positions closed: 65

1% more funds holding

Funds holding: 610 [Q1] → 617 (+7) [Q2]

0.95% less ownership

Funds ownership: 98.38% [Q1] → 97.43% (-0.95%) [Q2]

18% less capital invested

Capital invested by funds: $18.1B [Q1] → $14.8B (-$3.3B) [Q2]

57% less call options, than puts

Call options by funds: $5.56M | Put options by funds: $12.9M

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$210

8%

upside

Avg. target

$232

19%

upside

High target

$241

24%

upside

6 analyst ratings

5 positive

83%

1 neutral

17%

0 negative

0%

TD Cowen Joseph Giordano 37% 1-year accuracy 7 / 19 met price target	18%upside $230	Buy Maintained	7 Aug 2024
DA Davidson Matt Summerville 41% 1-year accuracy 11 / 27 met price target	8%upside $210	Neutral Maintained	5 Aug 2024
Oppenheimer Bryan Blair 73% 1-year accuracy 24 / 33 met price target	22%upside $238	Outperform Maintained	5 Aug 2024
RBC Capital Deane Dray 61% 1-year accuracy 37 / 61 met price target	21%upside $236	Outperform Maintained	2 Aug 2024
Baird Michael Halloran 27% 1-year accuracy 6 / 22 met price target	24%upside $241	Outperform Maintained	2 Aug 2024

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about IEX published over the past 30 days

IDEX Corporation Completes Acquisition of Mott Corporation

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) (“IDEX”) has completed its previously-announced acquisition of Mott Corporation and its subsidiaries (“Mott”), expanding IDEX's applied material science technology capabilities in high-value end markets. Mott is a leader in the design and manufacturing of sintered porous material structures and flow control solutions, with deep applied material science knowledge and process control capabilities. For more than 60 years, Mott has sol.

IDEX Corporation Completes Acquisition of Mott Corporation

IDEX Corp. Q2: Project Delay And Weakness In Life Science

I reiterate a 'Buy' rating for IDEX, with a fair price target of $220 per share, despite near-term headwinds in organic revenue and market softness. IDEX's acquisition of Mott Corporation for $1 billion is strategically favorable, enhancing their applied material science technology and potentially improving overall margins. Project delays and market weakness, particularly in the life science sector, have led to a 4% organic revenue decline and lowered full-year growth guidance.

IDEX Corp. Q2: Project Delay And Weakness In Life Science

Zacks Investment Research

Idex (IEX) Up 4.5% Since Last Earnings Report: Can It Continue?

Idex (IEX) reported earnings 30 days ago. What's next for the stock?

Idex (IEX) Up 4.5% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

Here's Why You Should Avoid Investing in IDEX (IEX) for Now

Softness in the analytical instrumentation, life sciences and semiconductor markets and increasing operating expenses weigh on IDEX (IEX). Unfavorable foreign currency movement is an added concern.

Here's Why You Should Avoid Investing in IDEX (IEX) for Now

IDEX Corporation Announces Pricing of Public Offering of Senior Notes

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) (“IDEX” or the “company”) today announced the pricing of its public offering of $500 million principal amount of 4.950% Senior Notes due 2029. The notes will be unsecured senior obligations that rank equal in right of payment to all of IDEX's existing and future senior indebtedness. Closing of the offering is expected to occur on August 21, 2024, subject to the satisfaction of customary closing conditions. IDEX estimates that the n.

IDEX Corporation Announces Pricing of Public Offering of Senior Notes

Zacks Investment Research

Idex (IEX) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Idex (IEX) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Idex (IEX) Reports Q2 Earnings: What Key Metrics Have to Say

IDEX Corporation (IEX) Q2 2024 Earnings Call Transcript

IDEX Corporation (NYSE:IEX ) Q2 2024 Earnings Conference Call August 1, 2024 10:30 AM ET Company Participants Wendy Palacios - Vice President, Investor Relations, FP&A Eric Ashleman - Chief Executive Officer & President Abhi Khandelwal - Senior Vice President & Chief Financial Officer Conference Call Participants Mike Halloran - Baird Vlad Bystricky - Citigroup Nathan Jones - Stifel Deane Dray - RBC Capital Markets Matt Summerville - D.A. Davidson Joe Giordano - Cowen Andrew Buscaglia - BNP Paribas Rob Wertheimer - Melius Research Operator Hello, and welcome to the IDEX Corporation Q2 2024 Earnings Conference Call and Webcast.

IDEX Corporation (IEX) Q2 2024 Earnings Call Transcript

Zacks Investment Research

IDEX (IEX) Q2 Earnings Top Estimates, Sales Miss, '24 View Down

IDEX's (IEX) second-quarter 2024 net sales decrease 5% due to lower sales in the Fluid & Metering Technologies and Health & Science Technologies segments.

IDEX (IEX) Q2 Earnings Top Estimates, Sales Miss, '24 View Down

Zacks Investment Research

Idex (IEX) Beats Q2 Earnings Estimates

Idex (IEX) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings of $2.18 per share a year ago.

Idex (IEX) Beats Q2 Earnings Estimates

IDEX Reports Second Quarter Results and Updates 2024 Outlook

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2024. “IDEX teams delivered strong execution in the second quarter, expanding margins sequentially despite stronger uncertainty-fueled macro headwinds,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. “As we tune the portfolio for sustained growth performance, our business leaders are deploying focused resources to our bes.

IDEX Reports Second Quarter Results and Updates 2024 Outlook

See News Rankings